Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAR | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | BTG2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | MBD2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | SP140 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | SUMO3 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
mRNA | IL21R | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | MAP4K1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
mRNA | DDHD1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |